Subfascial-located contraceptive devices requiring surgical removal.

Justin E Hellwinkel, Matthew W Konigsberg, Johana Oviedo, Paula M Castaño, R Kumar Kadiyala
{"title":"Subfascial-located contraceptive devices requiring surgical removal.","authors":"Justin E Hellwinkel,&nbsp;Matthew W Konigsberg,&nbsp;Johana Oviedo,&nbsp;Paula M Castaño,&nbsp;R Kumar Kadiyala","doi":"10.1186/s40834-021-00158-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Subdermal etonogestrel implants are highly effective contraceptive methods. Despite standardization of insertion technique by the manufacturer, some implants are inadvertently placed too deeply within or below the plane of the biceps brachii fascia. Placement of these implants in a deep tissue plane results in more difficult removal, which is not always possible in the office setting. In rare cases, surgical removal by an upper extremity surgeon is warranted.</p><p><strong>Case presentation: </strong>Here we present 6 cases of etonogestrel implants located in a subfascial plane requiring removal by an upper extremity surgeon. Implants were all localized with plain radiography and ultrasound prior to surgical removal. All cases had implants located in the subfascial plane and one was identified intramuscularly. The average age was 28 years (19-33) and BMI was 24.0 kg/m^2 (19.1-36.5), with the most common reason for removal being irregular bleeding. The majority of cases (5/6) were performed under monitored anesthesia care with local anesthetic and one case utilized regional anesthesia. All implants were surgically removed without complication.</p><p><strong>Conclusions: </strong>Insertion of etonogestrel contraceptive implants deep to the biceps brachii fascia is a rare, but dangerous complication. Removal of these implants is not always successful in the office setting and referral to an upper extremity surgeon is necessary to avoid damage to delicate neurovascular structures for safe removal.</p>","PeriodicalId":10637,"journal":{"name":"Contraception and Reproductive Medicine","volume":"6 1","pages":"13"},"PeriodicalIF":0.0000,"publicationDate":"2021-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40834-021-00158-5","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contraception and Reproductive Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40834-021-00158-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Background: Subdermal etonogestrel implants are highly effective contraceptive methods. Despite standardization of insertion technique by the manufacturer, some implants are inadvertently placed too deeply within or below the plane of the biceps brachii fascia. Placement of these implants in a deep tissue plane results in more difficult removal, which is not always possible in the office setting. In rare cases, surgical removal by an upper extremity surgeon is warranted.

Case presentation: Here we present 6 cases of etonogestrel implants located in a subfascial plane requiring removal by an upper extremity surgeon. Implants were all localized with plain radiography and ultrasound prior to surgical removal. All cases had implants located in the subfascial plane and one was identified intramuscularly. The average age was 28 years (19-33) and BMI was 24.0 kg/m^2 (19.1-36.5), with the most common reason for removal being irregular bleeding. The majority of cases (5/6) were performed under monitored anesthesia care with local anesthetic and one case utilized regional anesthesia. All implants were surgically removed without complication.

Conclusions: Insertion of etonogestrel contraceptive implants deep to the biceps brachii fascia is a rare, but dangerous complication. Removal of these implants is not always successful in the office setting and referral to an upper extremity surgeon is necessary to avoid damage to delicate neurovascular structures for safe removal.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
需要手术切除的筋膜下避孕装置。
背景:依托孕酮皮下植入是一种非常有效的避孕方法。尽管制造商对植入技术进行了标准化,但有些植入物还是在不经意间植入肱二头肌筋膜平面内或下方过深。将这些植入物放置在深层组织平面会导致更困难的移除,这在办公室环境中并不总是可能的。在极少数情况下,由上肢外科医生进行手术切除是必要的。病例介绍:在这里,我们报告了6例依托诺孕酮植入物位于筋膜下平面,需要上肢外科医生移除。植入物均在手术切除前通过平片和超声定位。所有病例的植入物均位于筋膜下平面,其中一例在肌肉内。平均年龄28岁(19-33岁),BMI为24.0 kg/m^2(19.1-36.5),最常见的切除原因是不规则出血。多数病例(5/6)采用局麻监护麻醉,1例采用区域麻醉。所有植入物均手术取出,无并发症。结论:依托孕酮植入肱二头肌筋膜是一种罕见但危险的并发症。在办公室移除这些植入物并不总是成功的,需要转诊给上肢外科医生,以避免损伤脆弱的神经血管结构,以确保安全移除。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Correction: Unintended pregnancy and contraceptive use among women in low- and middle-income countries: systematic review and meta-analysis Male characteristics and contraception in four districts of the central region, Ghana. Postpartum family planning uptake in Uganda: findings from the lot quality assurance sampling survey. Assessing the sustainability of two independent voucher-based family planning programs in Pakistan: a 24-months post-intervention evaluation. Emergency contraceptive use of Metronidazole among University female students in Dodoma region of Tanzania: a descriptive cross-sectional study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1